Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Tang F, Xu D, Wang S, Wong CK, et al. Science 2022;376:eabe1505.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tang F, Xu D, Wang S, Wong CK, et al. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 2022;376:eabe1505.
PMID: 35617398